Last reviewed · How we verify
NCT04023825: Suprazyg
Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children
NA trial testing suprazygomatic maxillary nerve block in Cleft Palate. Withdrawn.
1 July 2022
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 July 2019 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 July 2022 |
Drugs / interventions tested
- suprazygomatic maxillary nerve block — full drug profile →
Conditions studied
- Cleft Palate — all drugs for Cleft Palate →
- Surgery — all drugs for Surgery →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
Adults 5 Months to 12, any sex, with Cleft Palate or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a monocentric prospective randomized simple-blind designed study evaluating the superiority of the suprazygomatic maxillary nerve block in analgesia after cleft palate surgery compared with a control group. Every two hours, nurses systematically reassess the patient's pain and adjust the analgesic medications. Analgesic requirement, incidence of respiratory complications, re-feeding time and the duration of hospitalization are evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04023825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cleft Palate
Currently open trials in the same condition.
- NCT06962306 — Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery · Phase 4 · recruiting
- NCT06856330 — Effect of Furlow Palatoplasty With Buccal Myomucosal Flap on the Speech Development · recruiting
- NCT06420336 — QL vs LAI for Palatoplasty · NA · recruiting
- NCT05778903 — Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic Approach · NA · recruiting
- NCT04928391 — A Single Bolus of Dexmedetomidine Versus Normal Saline in Postoperative Agitation · Phase 3 · recruiting
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04023825 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 23 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing